EBS News and Press, Emergent Biosolutions Inc. From 10/19/23

GAITHERSBURG, Md., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, November 2, 2023, at 5:00 pm eastern time to discuss the financial results for the third quarter of 2023, recent business developments, and financial outlook for fu...

Emergent BioSolutions Partners with Emmitt Smith to Launch Ready to Rescue Campaign to Help Save Lives Amidst Rising Opioid Epidemic PR Newswire Professional Football Hall of Famer partners with Emergent to raise awareness of the dangers of opioid use and the importance of bei...

GAITHERSBURG, Md., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the appointment of Neal Fowler and Don DeGolyer to its Board of Directors effective October 1, 2023, with initial terms expiring at Emergent’s 2024 Annual Meeting of Stockholders. Bo...

2023-09-25 00:09:00 ET Summary For the week, the S&P 500 was down 2.9%. The best performer last week was Volatility, as investors were willing to pay higher premiums to hedge their downside risk. Transportation and Healthcare stocks held up the best last week, while defens...

2023-08-30 08:09:11 ET More on Emergent Emergent BioSolutions Is Clearly Risky, But The Reward Could Be Substantial Financial Woes Darken Emergent BioSolutions' Outlook (Rating Downgrade) Emergent BioSolutions Inc. 2023 Q2 - Results - Earnings Call Presentation ...

Emergent has officially shipped its over the counter, original prescription strength NARCAN ® Naloxone HCl Nasal Spray 4 mg to leading mass, drug/pharmacy and grocery stores, as well as online retailers NARCAN ® Nasal Spray will be the first, life-saving emergency medicine...

2023-08-29 18:01:53 ET More on Emergent Biosolutions Emergent BioSolutions Is Clearly Risky, But The Reward Could Be Substantial Financial Woes Darken Emergent BioSolutions' Outlook (Rating Downgrade) Emergent BioSolutions Inc. 2023 Q2 - Results - Earnings Call Prese...

2023-08-23 09:22:46 ET Summary Emergent BioSolutions is facing equity issuance and significant debt covenants in Q1 2024, but at its core, this is a robust pharma supplier to the U.S. government. The underlying value of the business is likely in excess of the price, even taking ac...

2023-08-22 10:00:48 ET Gainers: Fulcrum Therapeutics ( FULC ) +55% . Renovaro Biosciences ( RENB ) +18% . ProMIS Neurosciences ( PMN ) +17% . cbdMD ( YCBD ) +9% . 60 Degrees Pharmaceuticals ( SXTP ) +7% . Losers: Emergent BioSo...

2023-08-22 08:18:03 ET Tingo Group ( TIO ) -29% postpones Q2 results yet again after Hindenburg short report . Dragonfly Energy Holdings Corp. ( DFLI ) -20% after Q2 earning release . DICK'S Sporting Goods ( DKS ) -19% after Q2 earning release ....